1.
|
Phase: Phase III Type: Natural history/Epidemiology, Prevention Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
|
|
2.
|
Phase: Phase III Type: Natural history/Epidemiology Status: Active Age: 55 and over (50 and over for African Americans) Sponsor: NCI, Other Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225
|
|
3.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-0580-B, NCT00744549
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-0604-CE, NCT00844792
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BTC-W1, NCT01508221
|
|
6.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ORT-OXI-2009, NCT01822405
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 120901, CDR0000642446, IRB#0220090065, CINJ-120901, NCT00905918
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: BSMMU-002-CT, NCT01735097
|